Pro-HPV Vaccine Doc Omits Financial Ties in Medical Journal
One of the biggest promoted drugs in history, the HPV cervical cancer vaccine, is a multi-billion dollar blockbuster. But it’s also faced criticism — some of it from a scientist who helped develop it — amid concerns about safety and effectiveness
When Japan suspended proactively recommending the vaccine amid concerns over injuries, the makers, Merck (Gardasil) and GlaxoSmithKline (Cevarix), began the hard lobby.
Enter a physician who wrote a correspondence about the controversy in this week’s online version of The Lancet medical journal. Dr. Sharon J.B. Hanley defended the HPV vaccine and dismissed reports of side effects blaming the “media” environment for all the fuss. There’s just one key fact that she left out…
2008 December: President Obama nominates Hillary Clinton for secretary of state. 2009 Jan. 13: Reports say the clintonemail.com domain was established. Jan. 21: Senate confirms Clinton as secretary of state. March 18: Clinton will later name this as the date she began using a private server for government business. 2012 Sept. 11: Islamic extremists launch […]